Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study
Extracorporeal membrane oxygenation (ECMO) represents a viable therapy option for patients with refractory acute respiratory distress syndrome (ARDS). Currently, veno-venous (vv) ECMO is frequently used in patients suffering from coronavirus disease 2019 (COVID-19). VV-ECMO was also frequently utili...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4ed929e8c632471f8203aace771f5da9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4ed929e8c632471f8203aace771f5da9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4ed929e8c632471f8203aace771f5da92021-11-25T18:02:51ZClinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study10.3390/jcm102254402077-0383https://doaj.org/article/4ed929e8c632471f8203aace771f5da92021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5440https://doaj.org/toc/2077-0383Extracorporeal membrane oxygenation (ECMO) represents a viable therapy option for patients with refractory acute respiratory distress syndrome (ARDS). Currently, veno-venous (vv) ECMO is frequently used in patients suffering from coronavirus disease 2019 (COVID-19). VV-ECMO was also frequently utilised during the influenza pandemic and experience with this complex and invasive treatment has increased worldwide since. However, data on comparison of clinical characteristics and outcome of patients with COVID-19 and influenza-related severe ARDS treated with vv-ECMO are scarce. This is a retrospective analysis of all consecutive patients treated with vv/(veno-arterial)va-ECMO between January 2009 and January 2021 at the University Medical Centre Hamburg-Eppendorf in Germany. All patients with confirmed COVID-19 or influenza were included. Patient characteristics, parameters related to ICU and vv/va-ECMO as well as clinical outcomes were compared. Mortality was assessed up to 90 days after vv/va-ECMO initiation. Overall, 113 patients were included, 52 (46%) with COVID-19 and 61 (54%) with influenza-related ARDS. Median age of patients with COVID-19 and influenza was 58 (IQR 53–64) and 52 (39–58) years (<i>p</i> < 0.001), 35% and 31% (<i>p</i> = 0.695) were female, respectively. Charlson Comorbidity Index was 3 (1–5) and 2 (0–5) points in the two groups (<i>p</i> = 0.309). Median SAPS II score pre-ECMO was 27 (24–36) vs. 32 (28–41) points (<i>p</i> = 0.009), and SOFA score was 13 (11–14) vs. 12 (8–15) points (<i>p</i> = 0.853), respectively. Median P/F ratio pre-ECMO was 64 (46–78) and 73 (56–104) (<i>p</i> = 0.089); pH was 7.20 (7.16–7.29) and 7.26 (7.18–7.33) (<i>p</i> = 0.166). Median days on vv/va-ECMO were 17 (7–27) and 11 (7–20) (<i>p</i> = 0.295), respectively. Seventy-one percent and sixty-nine percent had renal replacement therapy (<i>p</i> = 0.790). Ninety-four percent of patients with COVID-19 and seventy-seven percent with influenza experienced vv/va-ECMO-associated bleeding events (<i>p</i> = 0.004). Thirty-four percent and fifty-five percent were successfully weaned from ECMO (<i>p</i> = 0.025). Ninety-day mortality was 65% and 57% in patients with COVID-19 and influenza, respectively (<i>p</i> = 0.156). Median length of ICU stay was 24 (13–44) and 28 (16–14) days (<i>p</i> = 0.470), respectively. Despite similar disease severity, the use of vv/va-ECMO in ARDS related to COVID-19 and influenza resulted in similar outcomes at 90 days. A significant higher rate of bleeding complications and thrombosis was observed in patients with COVID-19.Kevin RoedlAhmel KahnDominik JarczakMarlene FischerOlaf BoenischGeraldine de HeerChristoph BurdelskiDaniel FringsBarbara SensenAxel NierhausStephan BrauneYalin YildirimAlexander BernhardtHermann ReichenspurnerStefan KlugeDominic WichmannMDPI AGarticleCOVID-19coronavirus diseaseinfluenzamultiple organ failureARDSECMOMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5440, p 5440 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
COVID-19 coronavirus disease influenza multiple organ failure ARDS ECMO Medicine R |
| spellingShingle |
COVID-19 coronavirus disease influenza multiple organ failure ARDS ECMO Medicine R Kevin Roedl Ahmel Kahn Dominik Jarczak Marlene Fischer Olaf Boenisch Geraldine de Heer Christoph Burdelski Daniel Frings Barbara Sensen Axel Nierhaus Stephan Braune Yalin Yildirim Alexander Bernhardt Hermann Reichenspurner Stefan Kluge Dominic Wichmann Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| description |
Extracorporeal membrane oxygenation (ECMO) represents a viable therapy option for patients with refractory acute respiratory distress syndrome (ARDS). Currently, veno-venous (vv) ECMO is frequently used in patients suffering from coronavirus disease 2019 (COVID-19). VV-ECMO was also frequently utilised during the influenza pandemic and experience with this complex and invasive treatment has increased worldwide since. However, data on comparison of clinical characteristics and outcome of patients with COVID-19 and influenza-related severe ARDS treated with vv-ECMO are scarce. This is a retrospective analysis of all consecutive patients treated with vv/(veno-arterial)va-ECMO between January 2009 and January 2021 at the University Medical Centre Hamburg-Eppendorf in Germany. All patients with confirmed COVID-19 or influenza were included. Patient characteristics, parameters related to ICU and vv/va-ECMO as well as clinical outcomes were compared. Mortality was assessed up to 90 days after vv/va-ECMO initiation. Overall, 113 patients were included, 52 (46%) with COVID-19 and 61 (54%) with influenza-related ARDS. Median age of patients with COVID-19 and influenza was 58 (IQR 53–64) and 52 (39–58) years (<i>p</i> < 0.001), 35% and 31% (<i>p</i> = 0.695) were female, respectively. Charlson Comorbidity Index was 3 (1–5) and 2 (0–5) points in the two groups (<i>p</i> = 0.309). Median SAPS II score pre-ECMO was 27 (24–36) vs. 32 (28–41) points (<i>p</i> = 0.009), and SOFA score was 13 (11–14) vs. 12 (8–15) points (<i>p</i> = 0.853), respectively. Median P/F ratio pre-ECMO was 64 (46–78) and 73 (56–104) (<i>p</i> = 0.089); pH was 7.20 (7.16–7.29) and 7.26 (7.18–7.33) (<i>p</i> = 0.166). Median days on vv/va-ECMO were 17 (7–27) and 11 (7–20) (<i>p</i> = 0.295), respectively. Seventy-one percent and sixty-nine percent had renal replacement therapy (<i>p</i> = 0.790). Ninety-four percent of patients with COVID-19 and seventy-seven percent with influenza experienced vv/va-ECMO-associated bleeding events (<i>p</i> = 0.004). Thirty-four percent and fifty-five percent were successfully weaned from ECMO (<i>p</i> = 0.025). Ninety-day mortality was 65% and 57% in patients with COVID-19 and influenza, respectively (<i>p</i> = 0.156). Median length of ICU stay was 24 (13–44) and 28 (16–14) days (<i>p</i> = 0.470), respectively. Despite similar disease severity, the use of vv/va-ECMO in ARDS related to COVID-19 and influenza resulted in similar outcomes at 90 days. A significant higher rate of bleeding complications and thrombosis was observed in patients with COVID-19. |
| format |
article |
| author |
Kevin Roedl Ahmel Kahn Dominik Jarczak Marlene Fischer Olaf Boenisch Geraldine de Heer Christoph Burdelski Daniel Frings Barbara Sensen Axel Nierhaus Stephan Braune Yalin Yildirim Alexander Bernhardt Hermann Reichenspurner Stefan Kluge Dominic Wichmann |
| author_facet |
Kevin Roedl Ahmel Kahn Dominik Jarczak Marlene Fischer Olaf Boenisch Geraldine de Heer Christoph Burdelski Daniel Frings Barbara Sensen Axel Nierhaus Stephan Braune Yalin Yildirim Alexander Bernhardt Hermann Reichenspurner Stefan Kluge Dominic Wichmann |
| author_sort |
Kevin Roedl |
| title |
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| title_short |
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| title_full |
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| title_fullStr |
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| title_full_unstemmed |
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study |
| title_sort |
clinical characteristics, complications and outcomes of patients with severe acute respiratory distress syndrome related to covid-19 or influenza requiring extracorporeal membrane oxygenation—a retrospective cohort study |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/4ed929e8c632471f8203aace771f5da9 |
| work_keys_str_mv |
AT kevinroedl clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT ahmelkahn clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT dominikjarczak clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT marlenefischer clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT olafboenisch clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT geraldinedeheer clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT christophburdelski clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT danielfrings clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT barbarasensen clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT axelnierhaus clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT stephanbraune clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT yalinyildirim clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT alexanderbernhardt clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT hermannreichenspurner clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT stefankluge clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy AT dominicwichmann clinicalcharacteristicscomplicationsandoutcomesofpatientswithsevereacuterespiratorydistresssyndromerelatedtocovid19orinfluenzarequiringextracorporealmembraneoxygenationaretrospectivecohortstudy |
| _version_ |
1718411678129848320 |